# Implementation of Robotic-Assisted Sacrocervicopexy for Apical Organ Prolapse Using the Semitendinosus Tendon—Pilot Study and Analysis of Clinical Outcome

**Authors:** Carolin Schröder, Charlotte Lukannek, Eva K. Egger, Lucia A. Otten, Alexander Mustea, Dominique Koensgen

PMC · DOI: 10.1007/s00192-024-05975-1 · International Urogynecology Journal · 2024-11-12

## TL;DR

This study presents a new robotic-assisted surgical technique for treating apical organ prolapse using the semitendinosus tendon, showing improved patient outcomes with minimal complications.

## Contribution

The first worldwide use of robotic-assisted sacrocervicopexy with the semitendinosus tendon for apical organ prolapse is introduced and evaluated.

## Key findings

- Significant reduction in bladder and descensus symptoms in patients after surgery.
- No serious intra- or postoperative complications observed in ten patients.
- POP-Q stage at point C significantly improved post-surgery.

## Abstract

This video demonstrates a robotic-assisted sacrocervicopexy using the semitendinosus tendon.

Between June 2022 and February 2023, we performed the worldwide first Da Vinci robotic-assisted sacrocervicopexies (SCP) for apical organ prolapse using the semitendinosus tendon of the left knee. Analysis of safety, feasibility, and clinical outcome of the first ten patients operated on using this new surgical technique included the German pelvic floor questionnaire (GPFQ) as well as a clinical examination.

Ten patients with a follow-up of 12 months were included. There was a significant reduction of the patient’s symptoms according to the GPFQ regarding the domain bladder (preoperatively versus 3 months postoperatively, mean 3.85 vs 1.61, p = 0.034), total score (preoperatively versus 3 months postoperatively, mean 12.79 vs 3.28, p = 0.034), and descensus symptoms (preoperatively versus 12 months postoperatively, mean 4.74 vs 0.67, p = 0.022). POP-Q stage (point C) was significantly reduced between the preoperative period and at the time of discharge (mean 2.2 vs 0, p = 0.004). No serious intra- and postoperative complications occurred.

This pilot study showed satisfying clinical outcomes after a follow-up of 12 months, with a low mid-term complication rate.

The online version contains supplementary material available at 10.1007/s00192-024-05975-1.

## Full-text entities

- **Diseases:** POP-Q (MESH:D011778), Apical Organ Prolapse (MESH:D056887)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12003600/full.md

---
Source: https://tomesphere.com/paper/PMC12003600